AUSTIN, Texas (AP) _ Lumos Pharma, Inc. (LUMO) on Wednesday reported a third-quarter loss of $7.5 million, after reporting a profit in the same period a year earlier.

The Austin, Texas-based company said it had a loss of 90 cents per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.06 per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LUMO at https://www.zacks.com/ap/LUMO

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News